Polymer-prodrug conjugates as candidates for degradable, long-acting implants, releasing the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine.
Journal Information
Full Title: J Mater Chem B
Abbreviation: J Mater Chem B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nanotechnology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest SPR, AO, CL, FYH, AS, KT, MN, AO, CFM and SPR are coinventors on a published patent application (WO2020128525) describing the presented polymers."
"The authors wish to thank the US National Institutes of Health (NIH) under grant number R01AI134091-01, for funding of this transatlantic collaboration. The authors also acknowledge the University of Liverpool Materials Innovation Factory for access to equipment, and the Centre of Excellence for Long-acting Therapeutics for access to analytical facilities. Manchester Organics Ltd are also acknowledged for the efficient scale up of compound 5 and the provision of high purity multi-gram samples."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025